Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma

Published:2023-02-17 Issue:3 Volume:77 Page:745-759
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Lu Zhou,Liu Ronghua,Wang Yining,Jiao Mengxia,Li Zhongchen,Wang Zhiqiang,Huang Cheng,Shi Guoming,Ke Aiwu,Wang Luman,Fu Ying,Xia Jie,Wen Haoyu,Zhou Jian,Wang Xiaoying,Ye Dan,Fan Jia,Chu Yiwei,Cai Jiabin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32442

Reference41 articles.

1. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 Edition);Liver Cancer,2020

2. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma;J Exp Clin Cancer Res,2019

3. The immunology of hepatocellular carcinoma;Nat Immunol,2018

4. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma;J Hepatol,2020

5. Immunotherapy for hepatocellular carcinoma: current and future;World J Gastroenterol,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TET2–STAT3–CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition;Journal of Experimental Medicine;2024-05-28

2. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives;Journal of Hematology & Oncology;2024-04-29

3. ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer;Cancer Discovery;2024-04-08

4. TET2 stabilized by deubiquitinase USP21 ameliorates cigarette smoke-induced apoptosis in airway epithelial cells;iScience;2024-03

5. Momordicine-I Suppresses Head and Neck Cancer Growth by Reprogrammimg Immunosuppressive Effect of the Tumor-Infiltrating Macrophages and B Lymphocytes;Molecular Cancer Therapeutics;2024-02-05